{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:24:38Z","timestamp":1792783478596,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100002327","name":"Kela","doi-asserted-by":"publisher","award":["76\/26\/2021"],"award-info":[{"award-number":["76\/26\/2021"]}],"id":[{"id":"10.13039\/501100002327","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Social Insurance Institution of Finland","id":[{"id":"https:\/\/ror.org\/057yw0190","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s40266-026-01335-4","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:10:08Z","timestamp":1790752208000},"page":"945-955","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-Term Proton Pump Inhibitor Therapy Is Common Among Older Adults: An 8-Year Finnish Nationwide Register Study"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3351-0981","authenticated-orcid":false,"given":"Leeni","family":"Minkkinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2061-2552","authenticated-orcid":false,"given":"Heini","family":"Kari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredriikka","family":"Nurminen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0288-9732","authenticated-orcid":false,"given":"Juho","family":"Lepp\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9844-5443","authenticated-orcid":false,"given":"Hanna","family":"Koskinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"issue":"9","key":"1335_CR1","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00228-023-03534-z","volume":"79","author":"LGT Shanika","year":"2023","unstructured":"Shanika LGT, Reynolds A, Pattison S, Braund R. Proton pump inhibitor use: systematic review of global trends and practices. Eur J Clin Pharmacol. 2023;79(9):1159\u201372. https:\/\/doi.org\/10.1007\/s00228-023-03534-z.","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"1335_CR2","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00228-023-03606-0","volume":"80","author":"HJ Song","year":"2024","unstructured":"Song HJ, Seo HJ, Jiang X, Jeon N, Lee YJ, Ha IH. Proton pump inhibitors associated with an increased risk of mortality in elderly: a systematic review and meta-analysis. Eur J Clin Pharmacol. 2024;80(3):367\u201382. https:\/\/doi.org\/10.1007\/s00228-023-03606-0.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"1335_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40266-025-01266-6","volume":"43","author":"J Bolt","year":"2026","unstructured":"Bolt J, Thompson W, Inglis C. Appropriate use of proton pump inhibitors in older adults: concerns and solutions. Drugs Aging. 2026;43(1):1\u20138. https:\/\/doi.org\/10.1007\/s40266-025-01266-6.","journal-title":"Drugs Aging"},{"issue":"4","key":"1335_CR4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s40264-024-01502-9","volume":"48","author":"N Brusselaers","year":"2025","unstructured":"Brusselaers N, Gudnadottir U, Engstrand L, Lilja HE. Trends in proton pump inhibitor use in Sweden by sex and age: a drug utilisation study. Drug Saf. 2025;48(4):389\u2013400. https:\/\/doi.org\/10.1007\/s40264-024-01502-9.","journal-title":"Drug Saf"},{"issue":"2","key":"1335_CR5","doi-asserted-by":"publisher","first-page":"244","DOI":"10.2174\/1574886318666230726124540","volume":"19","author":"M Ben-Eltriki","year":"2024","unstructured":"Ben-Eltriki M, Chhabra M, Cassels A, Wright JM. Inappropriate use of proton pump inhibitors among elderly patients in British Columbia: what are the long-term adverse events? Curr Drug Saf. 2024;19(2):244\u20137. https:\/\/doi.org\/10.2174\/1574886318666230726124540.","journal-title":"Curr Drug Saf"},{"key":"1335_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-069211","volume":"379","author":"B Farrell","year":"2022","unstructured":"Farrell B, Lass E, Moayyedi P, Ward D, Thompson W. Reduce unnecessary use of proton pump inhibitors. BMJ. 2022;379:e069211. https:\/\/doi.org\/10.1136\/bmj-2021-069211.","journal-title":"BMJ"},{"issue":"10447","key":"1335_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S0140-6736(24)00155-7","volume":"404","author":"MA Almadi","year":"2024","unstructured":"Almadi MA, Lu Y, Alali AA, Barkun AN. Peptic ulcer disease. Lancet. 2024;404(10447):68\u201381. https:\/\/doi.org\/10.1016\/S0140-6736(24)00155-7.","journal-title":"Lancet"},{"issue":"1","key":"1335_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5009\/gnl15502","volume":"11","author":"DS Strand","year":"2017","unstructured":"Strand DS, Kim D, Peura DA. 25 years of proton pump inhibitors: a comprehensive review. Gut Liver. 2017;11(1):27\u201337. https:\/\/doi.org\/10.5009\/gnl15502.","journal-title":"Gut Liver"},{"issue":"6","key":"1335_CR9","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s11894-008-0098-4","volume":"10","author":"JM Shin","year":"2008","unstructured":"Shin JM, Sachs G. Pharmacology of proton pump inhibitors. Curr Gastroenterol Rep. 2008;10(6):528\u201334. https:\/\/doi.org\/10.1007\/s11894-008-0098-4.","journal-title":"Curr Gastroenterol Rep"},{"issue":"7","key":"1335_CR10","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1136\/gutjnl-2017-314722","volume":"67","author":"CP Gyawali","year":"2018","unstructured":"Gyawali CP, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: the Lyon consensus. Gut. 2018;67(7):1351\u201362. https:\/\/doi.org\/10.1136\/gutjnl-2017-314722.","journal-title":"Gut"},{"issue":"8","key":"1335_CR11","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s00535-019-01572-y","volume":"54","author":"H Miwa","year":"2019","unstructured":"Miwa H, Igarashi A, Teng L, Uda A, Deguchi H, Tango T. Systematic review with network meta-analysis: indirect comparison of the efficacy of vonoprazan and proton-pump inhibitors for maintenance treatment of gastroesophageal reflux disease. J Gastroenterol. 2019;54(8):718\u201329. https:\/\/doi.org\/10.1007\/s00535-019-01572-y.","journal-title":"J Gastroenterol"},{"issue":"2","key":"1335_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/apt.16407","volume":"54","author":"EM Salvo","year":"2021","unstructured":"Salvo EM, Ferko NC, Cash SB, Gonzalez A, Kahrilas PJ. Umbrella review of 42 systematic reviews with meta-analyses: the safety of proton pump inhibitors. Aliment Pharmacol Ther. 2021;54(2):129\u201343. https:\/\/doi.org\/10.1111\/apt.16407.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"1335_CR13","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ajg.2012.444","volume":"108","author":"PO Katz","year":"2013","unstructured":"Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108(3):308\u201328. https:\/\/doi.org\/10.1038\/ajg.2012.444.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1335_CR14","doi-asserted-by":"publisher","first-page":"E170","DOI":"10.9778\/cmajo.20210240","volume":"11","author":"CE Aubert","year":"2023","unstructured":"Aubert CE, Blum MR, Gastens V, et al. Prescribing, deprescribing and potential adverse effects of proton pump inhibitors in older patients with multimorbidity. CMAJ Open. 2023;11(1):E170\u20138. https:\/\/doi.org\/10.9778\/cmajo.20210240.","journal-title":"CMAJ Open"},{"issue":"18","key":"1335_CR15","doi-asserted-by":"publisher","first-page":"e1771","DOI":"10.1212\/WNL.0000000000207747","volume":"101","author":"CA Northuis","year":"2023","unstructured":"Northuis CA, Bell EJ, Lutsey PL, et al. Cumulative use of proton pump inhibitors and risk of dementia. Neurology. 2023;101(18):e1771\u20138. https:\/\/doi.org\/10.1212\/WNL.0000000000207747.","journal-title":"Neurology"},{"issue":"9","key":"1335_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237676","volume":"15","author":"R Cooksey","year":"2020","unstructured":"Cooksey R, Kennedy J, Dennis MS, et al. Proton pump inhibitors and dementia risk. PLoS ONE. 2020;15(9):e0237676. https:\/\/doi.org\/10.1371\/journal.pone.0237676.","journal-title":"PLoS ONE"},{"issue":"9","key":"1335_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/2042098617715381","volume":"8","author":"ML Maes","year":"2017","unstructured":"Maes ML, Fixen DR, Linnebur SA. Adverse effects of proton-pump inhibitor use in older adults. Ther Adv Drug Saf. 2017;8(9):273\u201397. https:\/\/doi.org\/10.1177\/2042098617715381.","journal-title":"Ther Adv Drug Saf."},{"issue":"1","key":"1335_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/pds.4135","volume":"26","author":"SM Wallerstedt","year":"2017","unstructured":"Wallerstedt SM, Fastbom J, Linke J, Vitols S. Long-term use of proton pump inhibitors and prevalence of disease- and drug-related reasons for gastroprotection-a cross-sectional population-based study. Pharmacoepidemiol Drug Saf. 2017;26(1):9\u201316. https:\/\/doi.org\/10.1002\/pds.4135.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"1335_CR19","doi-asserted-by":"publisher","first-page":"e07595","DOI":"10.1016\/j.heliyon.2021.e07595","volume":"7","author":"M Rababa","year":"2021","unstructured":"Rababa M, Rababa\u2019h A. Inappropriate use of proton pump inhibitors among community-dwelling older adults. Heliyon. 2021;7(7):e07595. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e07595.","journal-title":"Heliyon."},{"issue":"9","key":"1335_CR20","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s00228-017-2273-8","volume":"73","author":"H Juntunen","year":"2017","unstructured":"Juntunen H, Taipale H, Tanskanen A, et al. Long-term use of proton pump inhibitors among persons with and without Alzheimer\u2019s disease. Eur J Clin Pharmacol. 2017;73(9):1149\u201358. https:\/\/doi.org\/10.1007\/s00228-017-2273-8.","journal-title":"Eur J Clin Pharmacol"},{"key":"1335_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ejim.2016.10.007","volume":"37","author":"V Savarino","year":"2017","unstructured":"Savarino V, Dulbecco P, de Bortoli N, Ottonello A, Savarino E. The appropriate use of proton pump inhibitors. Eur J Intern Med. 2017;37:19\u201324. https:\/\/doi.org\/10.1016\/j.ejim.2016.10.007.","journal-title":"Eur J Intern Med"},{"issue":"6","key":"1335_CR22","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1177\/17151635231203214","volume":"156","author":"R Dixon","year":"2023","unstructured":"Dixon R, Bolt J. Appropriateness of proton pump inhibitor therapy in an ambulatory geriatrics clinic. Can Pharm J (Ott). 2023;156(6):331\u20136. https:\/\/doi.org\/10.1177\/17151635231203214.","journal-title":"Can Pharm J (Ott)."},{"issue":"1","key":"1335_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1053\/j.gastro.2009.03.058","volume":"137","author":"C Reimer","year":"2009","unstructured":"Reimer C, S\u00f8ndergaard B, Hilsted L, Bytzer P. Proton-pump inhibitor therapy induces acid-related symptoms after withdrawal. Gastroenterology. 2009;137(1):80-87.e1. https:\/\/doi.org\/10.1053\/j.gastro.2009.03.058.","journal-title":"Gastroenterology"},{"issue":"6","key":"1335_CR24","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/j.1365-2036.2006.03084.x","volume":"24","author":"ES Bj\u00f6rnsson","year":"2006","unstructured":"Bj\u00f6rnsson ES, Abrahamsson H, Simr\u00e9n M, et al. Discontinuation of proton pump inhibitors. Aliment Pharmacol Ther. 2006;24(6):945\u201354. https:\/\/doi.org\/10.1111\/j.1365-2036.2006.03084.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"1335_CR25","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00228-019-02810-1","volume":"76","author":"M Lassalle","year":"2020","unstructured":"Lassalle M, Le Tri T, Bardou M, et al. Use of proton pump inhibitors in adults in France. Eur J Clin Pharmacol. 2020;76(3):449\u201357. https:\/\/doi.org\/10.1007\/s00228-019-02810-1.","journal-title":"Eur J Clin Pharmacol"},{"key":"1335_CR26","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1161\/CIRCULATIONAHA.108.191087","volume":"118","author":"DL Bhatt","year":"2008","unstructured":"Bhatt DL, Scheiman J, Abraham NS, et al. ACCF\/ACG\/AHA expert consensus document. Circulation. 2008;118:1894\u2013909. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.191087.","journal-title":"Circulation"},{"key":"1335_CR27","unstructured":"Kanta Services. Prescription service (Prescription Centre). 2025. https:\/\/www.kanta.fi\/en\/professionals\/prescription. Accessed 1 Mar 2026."},{"key":"1335_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k3532","volume":"363","author":"SM Langan","year":"2018","unstructured":"Langan SM, Schmidt SA, Wing K, et al. The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE). BMJ. 2018;363:k3532. https:\/\/doi.org\/10.1136\/bmj.k3532.","journal-title":"BMJ"},{"key":"1335_CR29","unstructured":"World Health Organization. Anatomical Therapeutic Chemical (ATC) classification system. 2026. https:\/\/www.who.int\/tools\/atc-ddd-toolkit\/atc-classification. Accessed 1 Mar 2026."},{"key":"1335_CR30","unstructured":"Statistics Finland. Population structure. 2026. https:\/\/stat.fi\/en\/statistics\/vaerak. Accessed 23 Jul 2026."},{"issue":"5","key":"1335_CR31","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1177\/1756283X16650156","volume":"9","author":"A Potteg\u00e5rd","year":"2016","unstructured":"Potteg\u00e5rd A, Broe A, Hallas J, de Muckadell OB, Lassen AT, L\u00f8drup AB. Use of proton-pump inhibitors among adults: a Danish nationwide drug utilization study. Ther Adv Gastroenterol. 2016;9(5):671\u20138. https:\/\/doi.org\/10.1177\/1756283X16650156.","journal-title":"Ther Adv Gastroenterol"},{"key":"1335_CR32","doi-asserted-by":"publisher","first-page":"175628481877794","DOI":"10.1177\/1756284818777943","volume":"11","author":"\u00d3\u00d6 H\u00e1lfd\u00e1narson","year":"2018","unstructured":"H\u00e1lfd\u00e1narson \u00d3\u00d6, Potteg\u00e5rd A, Bj\u00f6rnsson ES, et al. Proton-pump inhibitors among adults. Ther Adv Gastroenterol. 2018;11:1756284818777943. https:\/\/doi.org\/10.1177\/1756284818777943.","journal-title":"Ther Adv Gastroenterol"},{"key":"1335_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.552102","volume":"11","author":"M Matuz","year":"2020","unstructured":"Matuz M, Benk\u0151 R, Engi Z, et al. Use of proton pump inhibitors in Hungary. Front Pharmacol. 2020;11:552102. https:\/\/doi.org\/10.3389\/fphar.2020.552102.","journal-title":"Front Pharmacol"},{"issue":"11","key":"1335_CR34","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1111\/jgs.19164","volume":"72","author":"JF Huon","year":"2024","unstructured":"Huon JF, Sanyal C, Gagnon CL, et al. The cost of potentially inappropriate medications for older adults in Canada: a comparative cross-sectional study. J Am Geriatr Soc. 2024;72(11):3530\u201340. https:\/\/doi.org\/10.1111\/jgs.19164.","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"1335_CR35","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1111\/jgs.16779","volume":"68","author":"M Fralick","year":"2020","unstructured":"Fralick M, Bartsch E, Ritchie CS, Sacks CA. Estimating the use of potentially inappropriate medications among older adults in the United States. J Am Geriatr Soc. 2020;68(12):2927\u201330. https:\/\/doi.org\/10.1111\/jgs.16779.","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"1335_CR36","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.17988","volume":"7","author":"S Schietzel","year":"2024","unstructured":"Schietzel S, Zechmann S, Rachamin Y, Neuner-Jehle S, Senn O, Grischott T. Potentially inappropriate medication use in primary care in Switzerland. JAMA Netw Open. 2024;7(6):e2417988. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.17988.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"1335_CR37","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.cgh.2017.09.033","volume":"16","author":"DY Graham","year":"2018","unstructured":"Graham DY, Tansel A. Interchangeable use of proton pump inhibitors based on relative potency. Clin Gastroenterol Hepatol. 2018;16(6):800-808.e7. https:\/\/doi.org\/10.1016\/j.cgh.2017.09.033.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"1335_CR38","doi-asserted-by":"publisher","first-page":"e2419851","DOI":"10.1001\/jamanetworkopen.2024.19851","volume":"7","author":"M Carollo","year":"2024","unstructured":"Carollo M, Crisafulli S, Selleri M, Piccoli L, L\u2019Abbate L, Trifir\u00f2 G. Agreement of different drug-drug interaction checkers for proton pump inhibitors. JAMA Netw Open. 2024;7(7):e2419851. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.19851. (Published 2024 Jul 1).","journal-title":"JAMA Netw Open"},{"key":"1335_CR39","unstructured":"NHS Specialist Pharmacy Service. Using clopidogrel with proton pump inhibitors (PPIs). https:\/\/www.sps.nhs.uk\/articles\/using-clopidogrel-with-proton-pump-inhibitors-ppis\/. Accessed 7 Jun 2026."},{"issue":"7","key":"1335_CR40","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1111\/jgs.18372","volume":"71","author":"American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2023","unstructured":"American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria\u00ae. J Am Geriatr Soc. 2023;71(7):2052\u201381. https:\/\/doi.org\/10.1111\/jgs.18372.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"1335_CR41","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ageing\/afu145","volume":"44","author":"D O'Mahony","year":"2015","unstructured":"O\u2019Mahony D, O\u2019Sullivan D, Byrne S, O\u2019Connor MN, Ryan C, Gallagher P. STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213\u20138. https:\/\/doi.org\/10.1093\/ageing\/afu145.","journal-title":"Age Ageing"},{"issue":"12","key":"1335_CR42","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1080\/17512433.2023.2280219","volume":"16","author":"S McGettigan","year":"2023","unstructured":"McGettigan S, Curtin D, O\u2019Mahony D. STOPP\/START criteria: uptake and clinical impact. Expert Rev Clin Pharmacol. 2023;16(12):1175\u201385. https:\/\/doi.org\/10.1080\/17512433.2023.2280219.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"1335_CR43","unstructured":"Finnish Medical Society Duodecim. V\u00e4lt\u00e4 pitk\u00e4aikaista hoitoa dysepepsiassa. [Avoid long-term pharmacotherapy for dyspepsia.] Choosing Wisely Finland; 2021. https:\/\/www.kaypahoito.fi\/dnd00095. Accessed 1 Mar 2026."},{"issue":"1","key":"1335_CR44","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2020-000563","volume":"8","author":"PF Haastrup","year":"2021","unstructured":"Haastrup PF, Jarb\u00f8l DE, Thompson W, Hansen JM, S\u00f8ndergaard J, Rasmussen S. When does proton pump inhibitor treatment become long term? A scoping review. BMJ Open Gastroenterol. 2021;8(1):e000563. https:\/\/doi.org\/10.1136\/bmjgast-2020-000563.","journal-title":"BMJ Open Gastroenterol"},{"key":"1335_CR45","doi-asserted-by":"publisher","first-page":"7591045","DOI":"10.1155\/2019\/7591045","volume":"2019","author":"P Voukelatou","year":"2019","unstructured":"Voukelatou P, Vrettos I, Emmanouilidou G, et al. Predictors of inappropriate proton pump inhibitor use. Curr Gerontol Geriatr Res. 2019;2019:7591045. https:\/\/doi.org\/10.1155\/2019\/7591045.","journal-title":"Curr Gerontol Geriatr Res."},{"key":"1335_CR46","unstructured":"Ministry of Social Affairs and Health. Laatusuositus hyv\u00e4n ik\u00e4\u00e4ntymisen turvaamiseksi ja palvelujen parantamiseksi 2017\u20132019. [Quality recommendation to ensure good ageing and improve services 2017\u20132019.] Helsinki; 2017. https:\/\/urn.fi\/URN:ISBN:978-952-00-3960-8"},{"issue":"2","key":"1335_CR47","first-page":"8","volume":"22","author":"S Kuusisto","year":"2025","unstructured":"Kuusisto S, Koskinen H, Nurminen F, Kari H. Merkitt\u00e4v\u00e4 monil\u00e4\u00e4kitys ja i\u00e4kk\u00e4ill\u00e4 v\u00e4ltett\u00e4v\u00e4t l\u00e4\u00e4kkeet yleisi\u00e4 l\u00e4\u00e4kkeiden annosjakelussa. [Excessive polypharmacy and potentially inappropriate medications are common in automated dose dispensing]. Dosis. 2025;22(2):8\u201315.","journal-title":"Dosis."},{"issue":"4","key":"1335_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250567","volume":"16","author":"CJ Maxwell","year":"2021","unstructured":"Maxwell CJ, Mondor L, Pefoyo Kon\u00e9 AJ, Hogan DB, Wodchis WP. Sex differences in multimorbidity and polypharmacy trends: a repeated cross-sectional study of older adults in Ontario, Canada. PLoS ONE. 2021;16(4):e0250567. https:\/\/doi.org\/10.1371\/journal.pone.0250567.","journal-title":"PLoS ONE"},{"issue":"7","key":"1335_CR49","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1001\/jamainternmed.2013.2851","volume":"173","author":"M Maggio","year":"2013","unstructured":"Maggio M, Corsonello A, Ceda GP, et al. Proton pump inhibitors and risk of mortality. JAMA Intern Med. 2013;173(7):518\u201323. https:\/\/doi.org\/10.1001\/jamainternmed.2013.2851.","journal-title":"JAMA Intern Med"},{"issue":"3","key":"1335_CR50","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00228-021-03250-6","volume":"78","author":"LA Garc\u00eda Rodr\u00edguez","year":"2022","unstructured":"Garc\u00eda Rodr\u00edguez LA, Cea Soriano L, de Abajo FJ, et al. Trends in the use of oral anticoagulants, antiplatelets and statins in four European countries: a population-based study. Eur J Clin Pharmacol. 2022;78(3):497\u2013504. https:\/\/doi.org\/10.1007\/s00228-021-03250-6.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"1335_CR51","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1080\/00365521.2020.1853220","volume":"56","author":"PF Haastrup","year":"2021","unstructured":"Haastrup PF, Hansen JM, S\u00f8ndergaard J, Jarb\u00f8l DE. Proton pump inhibitor use among patients at risk of peptic ulcer bleeding: a nationwide register-based study. Scand J Gastroenterol. 2021;56(1):6\u201312. https:\/\/doi.org\/10.1080\/00365521.2020.1853220.","journal-title":"Scand J Gastroenterol"},{"issue":"11","key":"1335_CR52","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1007\/s10620-024-08663-8","volume":"69","author":"W El Hajj","year":"2024","unstructured":"El Hajj W, Nahon S, Fares E, et al. Prophylactic proton pump inhibitors in upper gastrointestinal bleeding: impact and underprescription in a French multicentric cohort. Dig Dis Sci. 2024;69(11):4053\u201362. https:\/\/doi.org\/10.1007\/s10620-024-08663-8.","journal-title":"Dig Dis Sci"},{"issue":"6","key":"1335_CR53","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/fampra\/cmu050","volume":"31","author":"P Haastrup","year":"2014","unstructured":"Haastrup P, Paulsen MS, Begtrup LM, Hansen JM, Jarb\u00f8l DE. Strategies for discontinuation of proton pump inhibitors: a systematic review. Fam Pract. 2014;31(6):625\u201330. https:\/\/doi.org\/10.1093\/fampra\/cmu050.","journal-title":"Fam Pract"},{"issue":"7","key":"1335_CR54","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s40266-025-01217-1","volume":"42","author":"N Haji","year":"2025","unstructured":"Haji N, Tejani AM, Tung A, et al. Deprescribing antipsychotics and proton pump inhibitors in long-term care: a prescribing portraits approach. Drugs Aging. 2025;42(7):665\u201373. https:\/\/doi.org\/10.1007\/s40266-025-01217-1.","journal-title":"Drugs Aging"},{"issue":"6","key":"1335_CR55","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1001\/jamainternmed.2026.0584","volume":"186","author":"JP Fournier","year":"2026","unstructured":"Fournier JP, Gaultier A, Riche VP, Tessier P, Rat C, Nguyen-Soenen J. Deprescribing intervention and reduction of proton pump inhibitor use in primary care: a cluster randomized clinical trial. JAMA Intern Med. 2026;186(6):668\u201376. https:\/\/doi.org\/10.1001\/jamainternmed.2026.0584.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"1335_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-020-01227-5","volume":"21","author":"W Thompson","year":"2020","unstructured":"Thompson W, Nissen M, Haastrup P, et al. Discussing proton pump inhibitor deprescribing: the views of Danish GPs and older patients. BMC Fam Pract. 2020;21(1):160. https:\/\/doi.org\/10.1186\/s12875-020-01227-5.","journal-title":"BMC Fam Pract"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-026-01335-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-026-01335-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-026-01335-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:53:14Z","timestamp":1792104794000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-026-01335-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":56,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1335"],"URL":"https:\/\/doi.org\/10.1007\/s40266-026-01335-4","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"21 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was based on administrative and secondary register data, and as such, no ethical approval was required according to the Finnish legislation. The Social Insurance Institution of Finland (Kela) approved the use of the data for the current study. According to the General Data Protection Regulation of the European Union and the Finnish Data Protection Act, processing of personal data is permitted without informed consent of study subjects if the task is carried out in the public interest, such as scientific research. The data used in the study were fully pseudonymized before the authors accessed the data. The study was conducted following good scientific practice, data protection guidelines and ethical standards.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Due to legal restrictions and data protection regulations of the administrative sources providing individual-level register data, the authors do not have the permission to make sensitive personal data available. Interested parties may apply for permissions to access the data from the centralized data permit authority Findata (\n                      \n                      ), info@findata.","order":3,"name":"Ethics","label":"Availability of Data and Material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The analytical code used in this study is available from the corresponding author upon reasonable request. Due to data protection regulations, the code is tailored to the secure research environment and cannot be used without the required data access permissions.","order":4,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was not required for this study, as it was based on pseudonymized register data and conducted in accordance with national data protection legislation and ethical guidelines.","order":5,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"LM:\u00a0conceptualization, methodology, validation, formal analysis, investigation, writing\u2014original draft, and writing\u2014review and editing.\u00a0HKa: conceptualization, methodology, validation, investigation, writing\u2014original draft, and writing\u2014review and editing.\u00a0FN:\u00a0conceptualization, methodology, software, data curation, validation, formal analysis, investigation, and writing\u2014review and editing.\u00a0JL: methodology, data curation, formal analysis, and writing\u2014review and editing. HKo:\u00a0conceptualization, methodology, validation, investigation, supervision, writing\u2014original and revised drafts, and writing\u2014review and editing.","order":7,"name":"Ethics","label":"Author Contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}